EHTH vs. MMC, AJG, AON, BRO, SLQT, WDH, TWFG, GOCO, RDZN, and ZBAO
Should you be buying eHealth stock or one of its competitors? The main competitors of eHealth include Marsh & McLennan Companies (MMC), Arthur J. Gallagher & Co. (AJG), AON (AON), Brown & Brown (BRO), SelectQuote (SLQT), Waterdrop (WDH), TWFG (TWFG), GoHealth (GOCO), Roadzen (RDZN), and Zhibao Technology (ZBAO). These companies are all part of the "insurance agents, brokers, & service" industry.
eHealth vs.
eHealth (NASDAQ:EHTH) and Marsh & McLennan Companies (NYSE:MMC) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, community ranking, profitability, valuation and analyst recommendations.
79.5% of eHealth shares are owned by institutional investors. Comparatively, 88.0% of Marsh & McLennan Companies shares are owned by institutional investors. 4.1% of eHealth shares are owned by company insiders. Comparatively, 0.4% of Marsh & McLennan Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Marsh & McLennan Companies has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Marsh & McLennan Companies, indicating that it is currently the more affordable of the two stocks.
In the previous week, Marsh & McLennan Companies had 23 more articles in the media than eHealth. MarketBeat recorded 34 mentions for Marsh & McLennan Companies and 11 mentions for eHealth. Marsh & McLennan Companies' average media sentiment score of 1.47 beat eHealth's score of 0.67 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media.
Marsh & McLennan Companies received 24 more outperform votes than eHealth when rated by MarketBeat users. However, 61.58% of users gave eHealth an outperform vote while only 61.28% of users gave Marsh & McLennan Companies an outperform vote.
Marsh & McLennan Companies has a net margin of 16.60% compared to eHealth's net margin of -7.58%. Marsh & McLennan Companies' return on equity of 32.60% beat eHealth's return on equity.
eHealth presently has a consensus price target of $6.38, indicating a potential upside of 14.66%. Marsh & McLennan Companies has a consensus price target of $241.93, indicating a potential upside of 7.20%. Given eHealth's stronger consensus rating and higher possible upside, research analysts clearly believe eHealth is more favorable than Marsh & McLennan Companies.
eHealth has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Marsh & McLennan Companies has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500.
Summary
Marsh & McLennan Companies beats eHealth on 14 of the 18 factors compared between the two stocks.
Get eHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for EHTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:EHTH) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy EHTH Stock Free EHTH Stock Alerts